Assessing the selective therapeutic efficacy of superparamagnetic erlotinib nanoparticles in lung cancer by using quantitative magnetic resonance imaging and a nuclear factor kappa-B reporter gene system
2018 ◽
Vol 14
(3)
◽
pp. 1019-1031
◽
2009 ◽
Vol 27
(7)
◽
pp. 895-906
◽
2004 ◽
Vol 08
(04)
◽
pp. 329-353
◽
2013 ◽
Vol 56
(16)
◽
pp. 6330-6338
◽
1993 ◽
pp. 255-259
◽
2020 ◽
Vol 15
(1)
◽
pp. i-124